tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market
VERV
Verve Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Verve Therapeutics (VERV) Stock News & Sentiment

Compare
577 Followers
Verve Therapeutics: Buy Rating Driven by FDA Clearance and Strong Market Potential
Premium
Ratings
Verve Therapeutics: Buy Rating Driven by FDA Clearance and Strong Market Potential
4d ago
VERV
Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments
Premium
Ratings
Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments
4d ago
VERV
Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements
Premium
Ratings
Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements
4d ago
VERV
Promising Outlook for Verve Therapeutics: FDA Clearance and Strategic Partnership Drive Buy Rating
Premium
Ratings
Promising Outlook for Verve Therapeutics: FDA Clearance and Strategic Partnership Drive Buy Rating
4d ago
VERV
Promising Progress and Strategic Partnerships Position Verve Therapeutics as a Compelling Buy Opportunity
Premium
Ratings
Promising Progress and Strategic Partnerships Position Verve Therapeutics as a Compelling Buy Opportunity
28d ago
VERV
Verve Therapeutics: Buy Rating Backed by Promising VERVE-102 Program and Strategic Catalysts
Premium
Ratings
Verve Therapeutics: Buy Rating Backed by Promising VERVE-102 Program and Strategic Catalysts
29d ago
VERV
Buy Rating for Verve Therapeutics: Promising Program Progress and Strong Financial Position
Premium
Ratings
Buy Rating for Verve Therapeutics: Promising Program Progress and Strong Financial Position
29d ago
VERV
More VERV News >

VERV News on the Web

William Blair Remains a Buy on Verve Therapeutics (VERV)
TipRanks News
Neutral
RBC Capital Keeps Their Buy Rating on Verve Therapeutics (VERV)
TipRanks News
Neutral
Verve Therapeutics Full Year 2024 Earnings: Beats Expectations
Yahoo Finance
Neutral
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Treace Medical Concepts (TMCI) and Jasper Therapeutics (JSPR)
TipRanks News
Neutral
Verve Therapeutics Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance
Neutral
Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates
Zacks
Neutral
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance
Neutral
Vertex ends gene editing research pact with Verve
BioPharma Dive
Neutral

News Score - Last 7 Days

Neutral
VERV
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VERV’s Media Buzz Sentiment?
1 articles about VERV were published this week. In an average week, 1 articles are published.
    What is VERV’s weekly average amount of articles?
    In an average week, 1 articles about VERV are published.
      What is VERV’s News Sentiment?
      50% of articles about VERV were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        ALCAlcon
        SLNOSoleno Therapeutics
        DYAIDyadic International
        ASMBAssembly Biosciences
        CLGNCollplant Holdings
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing